Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Squinto Stephen P
Relationship:   Director, 10% Owner
City:   Cheshire
State:   CT
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   238,160    

Indirect Shares

   6,290,493      
Direct Value   $19,437,710    

Indirect Value

   $19,013,945      
Total Shares   6,528,653      
Total Value   $38,451,655      


Alexion Pharmaceuticals Inc $19,437,710 Springworks Therapeutics, Inc. $0 Alexion Pharmaceuticals Inc $19,437,710 Springworks Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Alexion Pharmaceuticals Inc ALXN EVP, Chief Global Ops.... 2014-10-27 106,508 2013-10-28 104,186    Premium*  
            Springworks Therapeutics, Inc. SWTX Director, 10% Owner 2022-05-19 131,652 2022-05-19 6,186,307    Premium*  
* Premium Members only  

Records found :    148         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ALXN Alexion Pharmaceuticals I... EVP, Research and Development   •       –      –    2011-02-18 4 OE $20.58 $205,800 D/D 10,000 49,637 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research and Development   •       –      –    2011-02-18 4 S $94.42 $944,200 D/D (10,000) 39,637 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2011-03-02 4 S $99.11 $495,550 D/D (5,000) 39,637 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2011-03-02 4 OE $20.58 $102,900 D/D 5,000 44,637 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2011-07-11 4 S $50.00 $25,100 D/D (502) 78,270 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2011-07-26 4 S $57.34 $1,605,520 D/D (28,000) 78,270 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2011-07-26 4 OE $10.29 $288,120 D/D 28,000 106,270 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2011-07-27 4 S $57.27 $38,314 D/D (669) 77,601 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2011-09-23 4 A $0.00 $0 D/D 1,250 78,851 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2011-10-24 4 S $68.84 $3,654,394 D/D (52,740) 78,851 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2011-10-24 4 OE $11.92 $628,661 D/D 52,740 131,591 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2012-01-10 4 S $75.00 $42,150 D/D (562) 78,289 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2012-01-27 4 S $74.41 $49,334 D/D (663) 77,626 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2012-01-30 4 S $74.51 $223,828 D/D (3,004) 74,662 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2012-02-17 4 OE $11.92 $945,048 D/D 55,260 142,922 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2012-02-17 4 S $81.27 $4,495,938 D/D (55,260) 87,662 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2012-06-06 4 S $90.00 $4,500,000 D/D (50,000) 87,662 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2012-06-06 4 OE $17.65 $882,500 D/D 50,000 137,662 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2012-07-09 4 OE $17.98 $899,000 D/D 50,000 137,662 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2012-07-09 4 AS $100.34 $5,021,772 D/D (50,000) 87,662 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2012-07-27 4 AS $105.86 $10,800,149 D/D (100,668) 86,994 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2012-07-27 4 OE $17.98 $2,096,280 D/D 100,000 187,662 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2012-07-31 4 AS $105.01 $106,585 D/D (1,015) 85,979 0 -
ALXN Alexion Pharmaceuticals I... EVP, Head of R&D   •       –      –    2012-12-13 5 GA $0.00 $0 I/I 951 108,942 0 -
ALXN Alexion Pharmaceuticals I... EVP, Head of R&D   •       –      –    2013-01-28 4 S $94.50 $67,568 D/D (715) 85,264 0 -
  148  Records found
  1   2   3   4  5   6      
  Page 4 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us